{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:37:34Z","timestamp":1777603054329,"version":"3.51.4"},"reference-count":39,"publisher":"BMJ","issue":"6","funder":[{"name":"NHMRC Research Fellowship","award":["#1045280"],"award-info":[{"award-number":["#1045280"]}]},{"name":"NHMRC Practitioner Fellowship and the Dorothy Adele Edols Charitable Trust","award":["#529915"],"award-info":[{"award-number":["#529915"]}]},{"name":"Australian National Health and Medical Research Council","award":["NHMRC #1009844"],"award-info":[{"award-number":["NHMRC #1009844"]}]},{"name":"NHMRC Early Career Fellowship","award":["#1072987"],"award-info":[{"award-number":["#1072987"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec><jats:title>Background\/Aims<\/jats:title><jats:p>To determine if selective laser trabeculoplasty (SLT) is superior to topical medication as a first-line treatment for glaucoma on quality of life (QoL) and clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this international, longitudinal, multisite randomised controlled trial, treatment na\u00efve mild-to-moderate primary open angle or exfoliation glaucoma patients were randomised 1:1 to SLT or topical medication. Glaucoma-specific QoL (primary outcome) was measured using the Glaucoma Outcomes Assessment Tool (GOAT; 342 items, 12 domains). Secondary outcomes included rate of successful intraocular pressure (IOP) reduction (&gt;25% reduction from baseline) and presence of ocular surface disease including conjunctival hyperaemia and eyelid erythema. Our intention-to-treat analysis was performed at months 12 and 24.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 167 enrolled patients, 83 and 84 were randomised to SLT and topical medication, respectively; and 145 (n=75 SLT, n=70 medication) completed 24-month follow-up. While both treatment arms achieved significant within-group gains in GOAT outcomes at both endpoints, SLT patients reported a greater between-group improvement in \u2018social well-being\u2019 compared with medication patients (mean\u00b1SE=0.28\u00b10.13; p=0.034) at 24 months. At month 24, the rate of successful IOP reduction was 18.6% (95% CI 3.0% to 34.3%, p=0.022) higher (absolute difference) in the medication compared with SLT group. More individuals in the medication group had conjunctival hyperaemia and eyelid erythema compared with SLT at 24 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Overall, we did not find evidence that SLT was superior to medication in improving glaucoma-specific QoL. While we found superior IOP reduction in the medication arm, eyelid erythema and conjunctival hyperaemia were more prevalent in these patients compared with the SLT group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p>ACTRN12611000720910.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2018-313396","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T21:25:13Z","timestamp":1567718713000},"page":"813-821","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":33,"title":["Selective laser trabeculoplasty versus topical medication as initial glaucoma treatment: the glaucoma initial treatment study randomised clinical trial"],"prefix":"10.1136","volume":"104","author":[{"given":"Ghee Soon","family":"Ang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0417-2048","authenticated-orcid":false,"given":"Eva K","family":"Fenwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred Tau Liang","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan Eyn Kidd","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Casson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul R","family":"Healey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konrad","family":"Pesudovs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sutha","family":"Sanmugasundram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony P","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J","family":"Walland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G","family":"Crowston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8674-5705","authenticated-orcid":false,"given":"Ecosse Luc","family":"Lamoureux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"2023050406001307000_104.6.813.1","doi-asserted-by":"publisher","DOI":"10.1185\/03007990802379996"},{"key":"2023050406001307000_104.6.813.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013"},{"key":"2023050406001307000_104.6.813.3","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.120.10.1268"},{"key":"2023050406001307000_104.6.813.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00102-8"},{"key":"2023050406001307000_104.6.813.5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/CRD.0b013e318156ec64","article-title":"Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension","volume":"16","author":"Han","year":"2008","journal-title":"Cardiol Rev"},{"key":"2023050406001307000_104.6.813.6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11588830-000000000-00000","article-title":"Effects of common topical antiglaucoma medications on the ocular surface, eyelids and periorbital tissue","volume":"28","author":"Servat","year":"2011","journal-title":"Drugs Aging"},{"key":"2023050406001307000_104.6.813.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91129-0"},{"key":"2023050406001307000_104.6.813.8","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.121.7.957"},{"key":"2023050406001307000_104.6.813.9","first-page":"53","article-title":"Efficacy and safety of selective laser trabeculoplasty as a primary procedure for controlling intraocular pressure in primary open angle glaucoma and ocular hypertensive patients","volume":"8","author":"Mahdy","year":"2008","journal-title":"Sultan Qaboos Univ Med J"},{"key":"2023050406001307000_104.6.813.10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2147\/OPTH.S15952","article-title":"Long-Term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma","volume":"5","author":"Shazly","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"2023050406001307000_104.6.813.11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3928\/15428877-20101124-07","article-title":"The efficacy of low-energy selective laser trabeculoplasty","volume":"42","author":"Tang","year":"2011","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"2023050406001307000_104.6.813.12","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-013-9729-3"},{"key":"2023050406001307000_104.6.813.13","doi-asserted-by":"crossref","unstructured":"Li X , Wang W , Zhang X . Meta-Analysis of selective laser trabeculoplasty versus topical medication in the treatment of open-angle glaucoma. BMC Ophthalmol 2015;15:107.doi:10.1186\/s12886-015-0091-2","DOI":"10.1186\/s12886-015-0091-2"},{"key":"2023050406001307000_104.6.813.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2014.06.006"},{"key":"2023050406001307000_104.6.813.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2004.00839.x"},{"key":"2023050406001307000_104.6.813.16","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.052795"},{"key":"2023050406001307000_104.6.813.17","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200604000-00009"},{"key":"2023050406001307000_104.6.813.18","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.148510"},{"key":"2023050406001307000_104.6.813.19","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e318218287f"},{"key":"2023050406001307000_104.6.813.20","first-page":"742","article-title":"Quality of life in glaucoma patients after selective laser trabeculoplasty","volume":"10","author":"De Keyser","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"2023050406001307000_104.6.813.21","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2017-310877"},{"key":"2023050406001307000_104.6.813.22","doi-asserted-by":"crossref","unstructured":"Gazzard G , Konstantakopoulou E , Garway-Heath D , et al . Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (light): a multicentre randomised controlled trial. Lancet 2019. Epub ahead of print.","DOI":"10.1016\/S0140-6736(18)32213-X"},{"key":"2023050406001307000_104.6.813.23","doi-asserted-by":"crossref","unstructured":"Bozzani FM , Alavi Y , Jofre-Bonet M , et al . A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma. BMC Ophthalmol 2012;12:43.doi:10.1186\/1471-2415-12-43","DOI":"10.1186\/1471-2415-12-43"},{"key":"2023050406001307000_104.6.813.24","doi-asserted-by":"crossref","unstructured":"Lamoureux EL , Mcintosh R , Constantinou M , et al . Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the glaucoma initial treatment study): study protocol for a randomised controlled trial. Trials 2015;16:406.doi:10.1186\/s13063-015-0924-6","DOI":"10.1186\/s13063-015-0924-6"},{"key":"2023050406001307000_104.6.813.25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/IJG.0b013e318287ac11","article-title":"Identifying content for the glaucoma-specific item bank to measure quality-of-life parameters","volume":"24","author":"Khadka","year":"2015","journal-title":"J Glaucoma"},{"key":"2023050406001307000_104.6.813.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2007.00999.x"},{"key":"2023050406001307000_104.6.813.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7547.960"},{"key":"2023050406001307000_104.6.813.28","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0140-6736(95)90116-7","article-title":"Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents","volume":"345","author":"Diggory","year":"1995","journal-title":"The Lancet"},{"key":"2023050406001307000_104.6.813.29","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0095-4543(21)01100-3","article-title":"Management of depression in the elderly","volume":"16","author":"Williams","year":"1989","journal-title":"Prim Care"},{"key":"2023050406001307000_104.6.813.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00660-6"},{"key":"2023050406001307000_104.6.813.31","unstructured":"Jones L , Garway-Heath DF , Azuara-Blanco A , et al . United Kingdom glaucoma treatment study I. are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials?: evidence from the United Kingdom glaucoma treatment study. Ophthalmology 2018."},{"key":"2023050406001307000_104.6.813.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00874-0"},{"key":"2023050406001307000_104.6.813.33","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ajo.2017.01.019","article-title":"Tube versus trabeculectomy study G. quality of life in the tube versus trabeculectomy study","volume":"176","author":"Kotecha","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"2023050406001307000_104.6.813.34","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1167\/iovs.16-20950","article-title":"Diabetic retinopathy and macular edema quality-of-life item banks: development and initial evaluation using computerized adaptive testing","volume":"58","author":"Fenwick","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"2023050406001307000_104.6.813.35","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.134668"},{"key":"2023050406001307000_104.6.813.36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"key":"2023050406001307000_104.6.813.37","first-page":"441","article-title":"A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma","volume":"6","author":"Garcia-Feijoo","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"2023050406001307000_104.6.813.38","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31815c5f4f"},{"key":"2023050406001307000_104.6.813.39","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1097\/OPX.0000000000000542","article-title":"Ocular surface disease in glaucoma: effect of polypharmacy and preservatives","volume":"92","author":"Ramli","year":"2015","journal-title":"Optom Vis Sci"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2018-313396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T13:06:00Z","timestamp":1683205560000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2018-313396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,5]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,5,21]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/bjophthalmol-2018-313396"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313396","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,5]]}}}